{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-005666","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2025-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.845355+00:00","generated_at":"2026-05-27T00:44:10.638651+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Aspira Women's Health President resigns; appoints new director Ellen Beausang","bullets":["Dr. Sandra Milligan resigns as President effective Feb 21, 2025, for personal reasons.","Duties assumed by Jamie Sullivan (Chief of Staff) and Todd Pappas (VP R&D and Lab Ops).","Ellen Beausang appointed to board; she is President/Chief Commercial Officer of BioReference Health (since June 2022).","Beausang brings 25+ years experience from Pfizer, Thermo Fisher, Quest Diagnostics; no arrangement or related-party transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-005666","json":"https://secwatch.observer/filing/0001493152-25-005666.json","markdown":"https://secwatch.observer/filing/0001493152-25-005666.md","text":"https://secwatch.observer/filing/0001493152-25-005666.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000149315225005666/0001493152-25-005666-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000149315225005666/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T00:44:10.638651+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"470d832465","claim":"Sandra Milligan resigned as President at Aspira Women's Health Inc..","evidence_excerpt":"Dr. Sandra Milligan, the President of Aspira Women’s Health Inc. (the “Company”) informed the Board of Directors of the Company that she was resigning as President of the Company for personal reasons, effective February 21, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225005666/0001493152-25-005666-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President"}]},{"claim_id":"c46ee96977","claim":"Ellen Beausang was appointed as Director at Aspira Women's Health Inc..","evidence_excerpt":"the Board of Directors of the Company appointed Ellen Beausang as a director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225005666/0001493152-25-005666-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}